<DOC>
	<DOCNO>NCT01174056</DOCNO>
	<brief_summary>The purpose research study gain understand basic response lung inflammation specifically certain medication reduce inflammation alone combination another . Inflammation way body react irritation injury , involve red , warm , often painful swell affected tissue . `` Acute lung injury '' involve inflammation specific one area lung cause one several condition : infection , trauma , breathe toxic substance , etc . When lung injury severe , enough oxygen get body ; lead need mechanical support breathing ( mechanical ventilation ) , problem brain , heart organ function , case , death .</brief_summary>
	<brief_title>Evaluation Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Zileuton</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Healthy man woman , race ethnicity , age 19 44 year old Screening FEV1 FVC &gt; 90 % predict Screening oxygen saturation pulse oximetry &gt; 97 % room air Capable lying still supine within PET/CT scanner ~1.5 hour Capable follow instruction breathe protocol CT portion PET/CT Able willing give inform consent BMI &lt; 35 Pregnancy ( confirm qualitative urine hCG pregnancy test ) Lactation Active menstruation History cardiopulmonary disease Currently take prescription medication History tobacco use illicit drug use within past year Presence implant electronic medical device Enrollment another research study investigational drug Known allergy rosiglitazone zileuton Known allergy trimethoprim/sulfamethoxazole amoxicillin Known allergy drug routinely use bronchoscopy History chronic active liver disease acute liver disease within past 3 month SGOT &gt; 47 IU/L , SGPT &gt; 53 IU/L , bilirubin &gt; 1.1 mg/dl Inability lie flat 1.5 hour PET/CT scan follow breathe protocol instruction CT portion PET/CT Prior researchrelated radiation exposure within past year participation study would result exposure exceed limit define FDA RDRC regulation ( 21 CFR 361.1 ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Lung inflammation</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>fluorodeoxyglucose</keyword>
	<keyword>rosiglitazone</keyword>
	<keyword>zileuton</keyword>
	<keyword>lung anti-inflammatory therapy</keyword>
</DOC>